How many drugs treat Hypertensive urgency?

Drug Landscape tracks 6 marketed treatments for Hypertensive urgency (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hypertensive-urgency.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Hypertensive urgency — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypertensive urgency (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hypertensive urgency, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Corlopam	FENOLDOPAM	Pfizer	Dopaminergic Agonist	D(1A) dopamine receptor	1997-01-01
Cozaar	losartan	Merck & Co.	ARB (Angiotensin II receptor blocker)	AT1 receptor	1995-04-14
Cozaar	LOSARTAN POTASSIUM	Merck & Co.	Angiotensin 2 Receptor Blocker	Type-1 angiotensin II receptor	1995-01-01
Sodium Nitroprusside	NITROPRUSSIDE	Roche	Vasodilator	Atrial natriuretic peptide receptor 1	1974-01-01
Microzide	hydrochlorothiazide	Generic (originally Merck)	Thiazide Diuretic [EPC]	ACE	1959-01-01
Diuril	CHLOROTHIAZIDE	Salix Pharms	Thiazide Diuretic	Solute carrier family 12 member 3	1958-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Merck & Co. · 2 drugs in Hypertensive urgency
· 1 drug in Hypertensive urgency
Generic (originally Merck) · 1 drug in Hypertensive urgency
Pfizer · 1 drug in Hypertensive urgency
Roche · 1 drug in Hypertensive urgency
Salix Pharms · 1 drug in Hypertensive urgency

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hypertensive urgency:

Cite this brief

Drug Landscape (2026). Hypertensive urgency — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hypertensive-urgency. Accessed 2026-06-10.

Hypertensive urgency full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing